ストックスクリーナーアプリを入手
0.4072
1.04%
0.0042
前日終値:
$0.403
開ける：
$0.3999
24時間の取引高:
362.37K
Relative Volume:
0.37
時価総額：
$31.97M
収益：
$4.17M
当期純損益:
$-27.71M
株価収益率:
-1.1005
EPS:
-0.37
ネットキャッシュフロー:
$-22.23M
1週間 パフォーマンス:
-3.74%
1か月 パフォーマンス:
+15.88%
6か月 パフォーマンス:
-57.14%
1年 パフォーマンス:
-59.68%
1日の値動き範囲:
$0.3999
$0.4268
1週間の範囲:
$0.391
$0.439
52週間の値動き範囲:
$0.292
$1.65
Clearside Biomedical Inc Stock (CLSD) Company Profile
名前
Clearside Biomedical Inc
セクター
電話
678-270-3631
住所
900 NORTH POINT PARKWAY, ALPHARETTA, GA
CLSD を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CLSD
Clearside Biomedical Inc
|
0.4072 | 33.44M | 4.17M | -27.71M | -22.23M | -0.37 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Clearside Biomedical Inc Stock (CLSD) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-07-18 | ダウングレード | Chardan Capital Markets | Buy → Neutral |
| 2025-07-18 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2025-07-18 | ダウングレード | Stifel | Buy → Hold |
| 2024-08-21 | 開始されました | Chardan Capital Markets | Buy |
| 2024-06-25 | 開始されました | Oppenheimer | Outperform |
| 2021-12-15 | 再開されました | Wedbush | Outperform |
| 2021-07-29 | 開始されました | H.C. Wainwright | Buy |
| 2020-05-13 | 開始されました | ROTH Capital | Buy |
| 2019-08-09 | ダウングレード | Needham | Buy → Hold |
| 2018-11-05 | ダウングレード | Cowen | Outperform → Market Perform |
| 2018-11-05 | ダウングレード | JP Morgan | Overweight → Underweight |
| 2018-11-05 | ダウングレード | Stifel | Buy → Hold |
| 2018-03-06 | 繰り返されました | Needham | Buy |
| 2017-05-25 | 開始されました | JMP Securities | Mkt Outperform |
| 2017-02-24 | 開始されました | JP Morgan | Overweight |
| 2016-11-10 | 繰り返されました | Needham | Buy |
| 2016-10-24 | 繰り返されました | Stifel | Buy |
すべてを表示
Clearside Biomedical Inc (CLSD) 最新ニュース
Trendlines Converge — Decision Point for Clearside Biomedical Inc.Trade Entry Summary & Expert Curated Trade Setups - thegnnews.com
Clearside Biomedical Q2 2025 Earnings Misses Market Expectations, Triggering Negative Stock Reaction - AInvest
Published on: 2025-08-19 10:02:33 - 선데이타임즈
Clearside Biomedical Announces New Chairperson Appointment - MSN
Bullish Divergence Spotted in Clearside Biomedical Inc. Momentum2025 Top Gainers & AI Enhanced Trading Signals - sundaytimes.kr
Clearside Biomedical Inc. Consolidation Zone May Signal AccumulationWeekly Earnings Recap & Smart Swing Trading Techniques - beatles.ru
Clearside Biomedical Faces Delisting Risk and Names New Chairperson - AInvest
Clearside Biomedical Reports Strong Sales Growth Amid Mixed Financial Indicators in June 2025 - MarketsMojo
Is This a Bottoming Phase for Clearside Biomedical Inc.July 2025 Breakouts & Scalable Portfolio Growth Ideas - thegnnews.com
Sector ETF Data Correlates with Strength in Clearside Biomedical Inc.Quarterly Portfolio Review & Intraday High Probability Alerts - metal.it
Clearside Biomedical earnings beat by $0.04, revenue fell short of estimates - Investing.com Canada
Clearside Biomedical Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Is Clearside Biomedical Inc. trending in predictive chart modelsFree Growth Focused Entry Plan Suggestions - Newser
Chart based exit strategy for Clearside Biomedical Inc.Smart Safety Strategy With Real Data Analysis - Newser
Applying chart zones and confluence areas to Clearside Biomedical Inc.Weekly Return Plan for Conservative Traders - Newser
How Clearside Biomedical Inc. stock performs during market volatilityFree Triple Digit Growth Focused Trade Plan - Newser
Clearside Biomedical 2025 Q2 Earnings Narrowed Losses Amid Strong Revenue Surge - AInvest
Clearside Biomedical's Liquidity Crisis and Strategic Overhaul: A High-Risk Bet or a Path to Renewal? - AInvest
Clearside Biomedical CLSD 2025Q2 Earnings Preview Upside Potential on Strategic Collaborations - AInvest
Clearside Biomedical Q2 Earnings: Revenue Beats Estimates, Shares Down 59.7% YTD - AInvest
Clearside Biomedical, Inc. (CLSD) Reports Q2 Loss, Beats Revenue Estimates - Yahoo Finance
Clearside Biomedical Inc expected to post a loss of 10 cents a shareEarnings Preview - TradingView
Using data tools to time your Clearside Biomedical Inc. exitFree Low Volatility Stable Growth Picks - Newser
Clearside Biomedical Inc. stock prediction for this weekFree AI Driven Stock Trend Forecast - Newser
Custom watchlist performance reports with Clearside Biomedical Inc.Profit Target Planning with Exit Confidence - Newser
What makes Clearside Biomedical Inc. stock price move sharplyTrade Flow Monitor with Volume Tracker - Newser
Clearside Biomedical shares fall 2.17% intraday as Piper Sandler Companies acquires G Squared Capital Partners. - AInvest
Elliott Wave Theory Predicts Pullback in Clearside Biomedical Inc.Low Volatility Stable Growth Picks Rank High - metal.it
Published on: 2025-08-04 17:07:21 - metal.it
What analysts say about Clearside Biomedical Inc. stockExceptional gains - Jammu Links News
Is Clearside Biomedical Inc. a growth stock or a value stockUnlock powerful market trend analysis - Jammu Links News
Is it the right time to buy Clearside Biomedical Inc. stockUnlock powerful stock screening for profits - Jammu Links News
Why is Clearside Biomedical Inc. stock attracting strong analyst attentionBuild a diversified portfolio for risk mitigation - Jammu Links News
Is Clearside Biomedical Inc. stock overvalued or undervaluedInvest smarter with daily market updates - Jammu Links News
What are the latest earnings results for Clearside Biomedical Inc.Rapid growth opportunities - Jammu Links News
Does Clearside Biomedical Inc. stock perform well during market downturnsUnstoppable trading performance - Jammu Links News
How does Clearside Biomedical Inc. generate profit in a changing economyGet professional advice for market timing - Jammu Links News
When is Clearside Biomedical Inc. stock expected to show significant growthUnlock daily market insights for better decisions - Jammu Links News
How volatile is Clearside Biomedical Inc. stock compared to the marketSuperior trading gains - Jammu Links News
Should I hold or sell Clearside Biomedical Inc. stock in 2025Free Popular Stock Recommendations - Jammu Links News
How does Clearside Biomedical Inc. compare to its industry peersBuild wealth faster with disciplined trading - Jammu Links News
What are Clearside Biomedical Inc. company’s key revenue driversGet timely alerts on market movers - Jammu Links News
How Resilient Is Clearside Biomedical Inc. Stock During Economic DownturnsStock Entry Point Planner with Volume Spike - Newser
Clearside Biomedical Inc. Added to High Probability Setup ListChart Driven High Reward Trading Setup Presented - beatles.ru
Strategies to average down on Clearside Biomedical Inc.Market Stability and Long-Term Growth Outlook - Newser
Competitive Positioning of Clearside Biomedical Inc.: Is It Leading or LaggingEquity Market Return Forecast Model Update - Newser
Chart overlay techniques for tracking Clearside Biomedical Inc.Sector-Wise Equity Performance Trend Forecast - Newser
Advanced analytics toolkit walkthrough for Clearside Biomedical Inc.Triple Digit Gain Opportunity Watchlist - Newser
Automated trading signals detected on Clearside Biomedical Inc.Free Smart Allocation Stock Pick Insights - Newser
Clearside Biomedical Inc. stock outlook for YEARSwing Entry Risk Mitigation with Chart Analysis - Newser
Clearside Biomedical Inc (CLSD) 財務データ
収益
当期純利益
現金流量
EPS
Clearside Biomedical Inc (CLSD) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Chong Ngai Hang Victor | Chief Medical Officer |
Nov 01 '24 |
Buy |
1.00 |
36,500 |
36,500 |
100,000 |
0.94%
1.72%
大文字化:
|
ボリューム (24 時間):